Uncover key drivers, emerging technologies, and competitive movements shaping the contract development manufacturing organizations market from 2026–2035 with trusted insights from The Business Research Company
What was the valuation of the Contract Development Manufacturing Organizations Market in 2026, and what figure is it projected to hit by 2030?
The contract development manufacturing organizations market has experienced rapid expansion in recent years. It is projected to grow from $274.79 billion in 2025 to $309.9 billion in 2026, maintaining a compound annual growth rate (CAGR) of 12.8%. The historical growth of this market can be attributed to factors such as cost optimization through outsourcing, increasing r&d expenditure in pharmaceuticals, expanding generic drug production, growing regulatory complexity, and limited in-house manufacturing capacity.
The contract development manufacturing organizations market size is anticipated to experience substantial expansion over the coming years. It is projected to reach a value of $503.82 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. This projected growth can be attributed to several factors, including the increasing development of biologics and advanced therapies, a heightened need for adaptable manufacturing capabilities, the expansion of smaller and medium-sized pharmaceutical enterprises, escalating clinical trial endeavors, and the overall growth of the global pharmaceutical pipeline. Furthermore, significant trends expected during this period encompass a greater reliance on outsourcing for drug development and manufacturing processes, an escalating requirement for comprehensive CDMO services, the broadening of biologics and biosimilars production, an intensified emphasis on adherence to regulations and quality control, and the expansion of manufacturing capabilities within nascent pharmaceutical markets.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3885&type=smp
Which Drivers Are Affecting Market Participation In The Contract Development Manufacturing Organizations Market?
The market for contract development manufacturing organizations has experienced growth, driven by an increasing demand for pharmaceutical products, which itself stems from a rise in chronic diseases and an expanding geriatric population. This surge in chronic ailments and the aging demographic has prompted pharmaceutical companies to accelerate the production of biologics and biosimilars. Consequently, the majority of pharmaceutical firms are engaging contract production and manufacturing organizations, on a contractual basis, to manage and coordinate their various tasks, operations, and tests. For example, data from November 2023, provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association, indicated that the total pharmaceutical production in Europe reached €390,000 million ($422,803 million) in 2023, marking an increase from €363,300 million ($393,857 million) in 2022. Thus, the escalating demand for pharmaceutical products is a key factor propelling the expansion of the contract development manufacturing organizations market.
What Segment Classifications Make Up The Contract Development Manufacturing Organizations Market?
The contract development manufacturing organizations market covered in this report is segmented –
1) By Service: CMO, CRO
2) By Product: Small Molecules, Biologics
3) By End User: Big Pharma, Small and Mid-size Pharma, Generic Pharmaceutical Companies, Other End Users
Subsegments:
1) By CMO (Contract Manufacturing Organization): API (Active Pharmaceutical Ingredient) Manufacturing, Formulation Development, Finished Product Manufacturing, Packaging Services
2) By CRO (Contract Research Organization): Preclinical Research Services, Clinical Trial Management, Data Management And Biostatistics, Regulatory Affairs Consulting
What Trends Are Projected To Support The Growth Of The Contract Development Manufacturing Organizations Market?
Major companies active in the contract development and manufacturing organizations market are concentrating on innovative progress, such as Lifera, to increase revenues within their sector. Lifera operates as a commercial-scale contract development and manufacturing organization (CDMO). For example, in June 2023, the Public Investment Fund (PIF), Saudi Arabia’s global investment organization, initiated Lifera. Lifera will primarily concentrate on producing crucial biopharmaceutical items, including insulin, vaccinations, monoclonal antibodies, plasma treatments, cell and gene therapies, and advanced small chemicals. To boost local capacity and support domestic manufacturing in this industry, the company also plans to establish partnerships with leading domestic and international businesses and attract specific investments. Key objectives for Lifera include advancing formulation development, medication development, and manufacturing.
Which Leading Companies Dominate The Contract Development Manufacturing Organizations Market Share?
Major companies operating in the contract development manufacturing organizations market are Recipharm AB, AbbVie Contract Manufacturing LLC, Almac Group Limited, Baxter BioPharma Solutions LLC, Boehringer Ingelheim International GmbH, Catalent Pharma Solutions Inc., CMIC Holdings Co. Ltd., Covance Inc., Evotec SE, Famar Health Care Services Madrid SA, Jubilant Life Sciences Limited, Lonza Group Ltd., Patheon UK Limited, Pfizer CentreOne, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, Advanced BioScience Laboratories Inc., Adare Pharmaceuticals Inc., Aenova Holding GmbH, Ajinomoto Bio-Pharma Services, Albany Molecular Research Inc., Cambrex Corporation, CordenPharma International GmbH, EirGen Pharma Limited, Grand River Aseptic Manufacturing, Hovione LLC, Metrics Contract Services, NextPharma Technologies Holding Limited, Nitto Avecia Pharma Services Inc., Piramal Pharma Solutions Inc., Siegfried Holding AG, Therapure Biopharma Inc., Velesco Pharmaceutical Services, WuXi PharmaTech (Cayman) Inc.
Access The Complete Report For Deeper Market Insights:
How Does The Contract Development Manufacturing Organizations Market Perform Across Major Global Regions?
North America was the largest region in contract development manufacturing organizations market in 2025. The regions covered in the contract development manufacturing organizations market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Contract Development Manufacturing Organizations Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3885&type=smp
Browse Through More Reports Similar to the Global Contract Development Manufacturing Organizations Market 2026, By The Business Research Company
Contract Development Manufacturing Organizations Market Report 2026
Contract Research And Manufacturing Services Market Report 2026
Electronic Contract Manufacturing And Design Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model